Facebook
Twitter
LinkedIn
ForwardThe Fungus Among Us: Review of Multidrug-resistant Candida auris
Newark, DE US
March 8, 2024
This activity will describe the drug-resistance mechanism of Candida auris, as well as standard and potential drugs for treating C. auris infection. We will also review proper screening techniques that are recommended in the hospital setting. With this knowledge, healthcare professionals will be better equipped to combat the growing resistant rates of Candida auris.
Target Audience
- Pharmacists
- Pharmacy Technicians
- Other Healthcare Professionals
Learning Objectives
Pharmacists learning objectives
At the conclusion of this activity, pharmcists should be able to:
- Discuss testing and screening procedures to identify those infected or colonized with C. auris
- Identify persons at an increased risk of developing C. auris infection
- Review current recommendations on the management of C. auris
- Identify drug-resistant mechanisms of C. auris
- Review promising new antifungal drugs for the treatment of C. auris
Pharmacy technician learning objectives
At the conclusion of this activity, pharmacy technicians should be able to:
- Identify persons at an increased risk of developing C. auris infection
- Review current recommendations on the management of C. auris
- Review promising new antifungal drugs for the treatment of C. auris
Additional Information
| Attachment | Size |
|---|---|
 Helpful Tips for Users - Vizient CE System.pdf | 134.66 KB |
Christiana Hospital
4755 Ogletown Stanton Rd
Ammons Auditorium
Newark, DE
19718
United States
FACULTY
Planning Committee
Chidera Egeonu, PharmD
PGY1 Pharmacy Resident
ChristianaCare Hospital
Caragh Clayton, PharmD, BCPS
Clinical Pharmacist
ChristianaCare Hospital
Faculty
Chidera Egeonu, PharmD
PGY1 Pharmacy Resident
ChristianaCare Hospital
PGY1 Pharmacy Resident
ChristianaCare Hospital
DISCLOSURE
As an accredited provider of continuing education, Vizient, Inc. is dedicated to ensuring this activity presents learners with only accurate, balanced, scientifically justified recommendations, and is free from promotion, marketing, and commercial bias. In accordance with The Standards for Integrity and Independence in Accredited Continuing Education, all planners, faculty, and others in control of the educational content have disclosed the absence or existence of all financial relationships (of any dollar amount) with ineligible companies within the past 24 months.
Ineligible companies – those companies whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients.
It is Vizient’s policy that owners and employees of ineligible companies, and any individuals who refuse to disclose the absence or existence of financial relationships with any ineligible companies are disqualified from participating as planners or faculty.
Disclosure Statements
Absence of Relevant Financial Relationships
None of the planners, faculty, or others in a position to control content for this educational activity have relevant financial relationship(s) to disclose with ineligible companies whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients.
Statement of Content Validity
Vizient, Inc. educational activities are intended to assist healthcare teams advance their professional responsibilities in accordance with the definition of continuing education. It is the policy of Vizient, Inc. to review and ensure that all content and recommendations for patient care within accredited CE is evidenced-based, based on current science and clinical reasoning while ensuring the content is fair and balanced. All recommendations must conform to the generally accepted standards of experimental design, data collection, analysis, and interpretation. Vizient, Inc. does not permit accredited continuing education if it advocates for unscientific approaches to diagnosis or therapy, or if the education promotes recommendations, treatment, or manners of practicing healthcare that are determined to have risks or dangers that outweigh the benefits or are known to be ineffective in the treatment of patients.
FDA Off-Label Use
Faculty presenters are also expected to disclose any discussion of (1) off-label or investigational uses of FDA approved commercial products or devices or (2) products or devices not yet approved in the United States.
Usage Disclosure: “Off-label/unapproved drug uses or products are mentioned within this activity.”
Evidence-based Content: “Low/absence of evidence-based topics are mentioned within this activity.”
Disclaimer
The education provided through this activity is for continuing education purposes only. The views and opinions expressed in this activity are those of the faculty/presenters and do not necessarily reflect the views of Vizient, Inc.
Joint Accreditation Statement
In support of improving patient care, this activity has been planned and implemented by Vizient, Inc. and ChristianaCare. Vizient, Inc. is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
Designation Statement(s)
Pharmacists (CPE)
Vizient, Inc. designates this live activity for a maximum of 1.00 contact hours for Pharmacists.
Universal Activity Number: JA0006103-9999-24-022-L01-P
Pharmacy Technicians (CPE)
Vizient, Inc. designates this live activity for a maximum of 1.00 contact hours for pharmacy technicians.
Universal Activity Number: JA0006103-9999-24-022-L01-T
Other Healthcare Professionals (General CE Credit)
Vizient, Inc. will award all other healthcare professionals who successfully complete the activity a Certificate of Participation. Various state license boards and credentialing bodies accept certificates of participation from accredited CE activities to meet CE requirements for license renewals and re-certification. It is the responsibility of the participant to contact their state licensing board and/or certifying body for verification on credit eligibility reciprocity.
Available Credit
- 1.00 ACPE Pharmacist
- 1.00 ACPE Pharmacy Technician
- 1.00 General CE - Attendance